Neuroreplacement, growth factor, and small molecule neurotrophic approaches for treating Parkinson's disease.

Autor: O'Neill MJ; Eli Lilly and Co. Ltd., Lilly Research Centre, Erl Wood Manor, Windlesham Surrey GU20 6PH, United Kingdom., Messenger MJ, Lakics V, Murray TK, Karran EH, Szekeres PG, Nisenbaum ES, Merchant KM
Jazyk: angličtina
Zdroj: International review of neurobiology [Int Rev Neurobiol] 2007; Vol. 77, pp. 179-217.
DOI: 10.1016/S0074-7742(06)77006-4
Databáze: MEDLINE